Cafepharma Today

June 9 2025 - Merck claims study success with PCSK9 cholesterol pill
Merck claims study success with PCSK9 cholesterol pill
FDA limits Merck's Keytruda, Bristol Myers' Opdivo in stomach cancer
Drug imports plummeted in April despite tariff threat
Sanofi starts shipping RSV drug early as rival nears market
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Earnings Preview: Abbott to report 3Q earnings
Yahoo/AP
Monday, October 17, 2011 - 7:31pm
tags:
Abbott Laboratories, earnings
Par Pharma sues FDA, claiming free speech rights
Fierce Pharma
Monday, October 17, 2011 - 7:31pm
tags:
FDA, lawsuits, free speech, Par Pharmaceutical, off-label, Allergan
Roche's All-Oral Hep C Therapy Could Be First, Not Best, to Reach Market
TheStreet.com
Monday, October 17, 2011 - 1:22pm
tags:
Roche, M&A, Anadys, hepatitis C, Pegasys, setrobuvir, Merck, Victrelis, RG7128, Pharmasset
Infinity advances pancreatic cancer drug candidate
Bizjournals.com
Monday, October 17, 2011 - 1:20pm
tags:
Infinity, pancreatic cancer, IPI-926
With Earnings Around The Corner, Human Genome Continues To Drop
Seeking Alpha
Monday, October 17, 2011 - 12:09pm
tags:
earnings, Human Genome Sciences
Sequenom to Sell Down Syndrome Test 2 Years After Pullback
Bloomberg
Monday, October 17, 2011 - 12:08pm
tags:
Sequenom, Downs Syndrome
Watson Files ANDAs
Yahoo/Zacks.com
Monday, October 17, 2011 - 12:07pm
tags:
Watson Pharmaceuticals, Momenta, Noven, Daytrana, Pfizer, Embeda, Novartis, Sanofi, Lovenox
Eli Lilly & Co. Third Quarter Earnings Sneak Peek
Yahoo/Wall St. Cheat Sheet
Monday, October 17, 2011 - 12:05pm
tags:
Eli Lilly, earnings
Vertex Declines After Sales of Incivek Are Little Changed
Bloomberg
Monday, October 17, 2011 - 12:04pm
tags:
Vertex, Incivek, hepatitis C
KV Pharma Sues Former CEO Over $37M In Benefits
Pharmalot
Monday, October 17, 2011 - 9:37am
tags:
KV Pharmaceutical, Mark Hermelin
Vivus Resubmits Qnexa Obesity Drug After Birth-Defect Warning
Bloomberg
Monday, October 17, 2011 - 9:30am
tags:
warnings, Vivus, Qnexa, FDA, obesity
Swiss pharma giant Roche to buy US-based hepatitis C specialist Anadys for $230 million
Yahoo/AP
Monday, October 17, 2011 - 9:27am
tags:
Roche, M&A, Anadys, hepatitis C
Acura to receive royalties on sale of Pfizer drug
Yahoo/AP
Monday, October 17, 2011 - 9:26am
tags:
Pfizer, Acura Pharmaceuticals, abuse-resistant painkillers, Oxecta
Ampio's Rebound Goes Hand-In-Hand With Pipeline Progress
Seeking Alpha
Monday, October 17, 2011 - 9:24am
tags:
Ampio Pharmaceuticals, Ampion, Zertane
FDA skeptical of Teva's Azilect to slow Parkinson's
Globes, Israel
Sunday, October 16, 2011 - 7:10pm
tags:
Teva Pharmaceuticals, Azilect, Parkinson's Disease
Watson Pharma seeks to make generic Daytrana
BusinessWeek
Sunday, October 16, 2011 - 7:09pm
tags:
Watson Pharmaceuticals, Daytrana, generics, Noven, ADHD
Indian pharma firms to cut medicine rates in Pakistan by a third
Business Standard, India
Sunday, October 16, 2011 - 7:08pm
tags:
QLT's CEO Discusses Latanoprost Punctal Plug Delivery System Conference Call Transcript
Seeking Alpha
Sunday, October 16, 2011 - 7:06pm
tags:
QLT, Latanoprost Punctal Plug, glaucoma
Micromet Unveils Another Fast Route To Market, Marks Pfizer As Lead Competitor
Seeking Alpha
Sunday, October 16, 2011 - 7:05pm
tags:
Micromet, Pfizer, blinatumomab, acute lymphoblastic leukemia, leukemia, Bmab, SAR3419, Sanofi, inotuzumab, Genentech, Seattle Genetics
Par Pharma Files Suit Against FDA Rule, Citing 1st Amendment
WSJ
Saturday, October 15, 2011 - 6:17pm
tags:
Par Pharmaceutical, Megace ES, anorexia

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Taurine and Aging: Is There Anything to It?
In the Pipeline
Cleaning Up the Medical Literature
In the Pipeline
Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.